Medicare Enrolled

Dr. Nannette Crowley, M.D.

Rheumatology · Macon, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1508 HARDEMAN AVE, Macon, GA 31201
4787423704
In practice since 2006 (20 years)
NPI: 1902841307 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Crowley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crowley? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Crowley

Dr. Nannette Crowley is a rheumatology specialist in Macon, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Crowley performed 24,547 Medicare services across 627 unique beneficiaries.

Between the years covered by Open Payments, Dr. Crowley received a total of $24,583 from 54 pharmaceutical and/or device companies across 1410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Crowley is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 23% volume in GA $24,583 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,547
Medicare services
Top 23% in GA for rheumatology
627
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,227 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
19,482 $10 $84
Infliximab-abda biosimilar injection, 10 mg
This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product.
3,680 $29 $185
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
506 $79 $180
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
241 $47 $210
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
162 $21 $150
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
146 $90 $600
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
97 $110 $385
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
63 $11 $77
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
54 $11 $68
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
45 $17 $110
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
31 $4 $20
X-ray of hand, 2 views
An X-ray imaging test of the hand using two different angles to visualize the bones and joints.
27 $22 $101
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
13 $19 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
80.9% high complexity
16.3% medium
2.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$24,583
Total received (2018-2024)
Avg $3,512/year across 7 years
Top 10% in GA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
1,410
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,784 (88.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,707 (11.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$91 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,339
2023
$3,274
2022
$3,066
2021
$3,134
2020
$1,797
2019
$3,533
2018
$6,441

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$707
Amgen Inc.
$484
Janssen Biotech, Inc.
$377
UCB, Inc.
$274
Aurinia Pharma U.S., Inc.
$261
Novartis Pharmaceuticals Corporation
$250
PFIZER INC.
$227
GlaxoSmithKline, LLC.
$160
Sandoz Inc.
$118
AstraZeneca Pharmaceuticals LP
$112
ANI Pharmaceuticals, Inc.
$79
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Organon Llc
$42
SCILEX PHARMACEUTICALS INC.
$38
GENZYME CORPORATION
$32
Biocon Biologics Inc
$24
E.R. Squibb & Sons, L.L.C.
$24
Kyowa Kirin, Inc.
$23
Lilly USA, LLC
$22
Radius Health, Inc.
$21
Alexion Pharmaceuticals, Inc.
$19
Top 3 companies account for 47.0% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$4,659
Amgen Inc.
$3,109
Janssen Biotech, Inc.
$1,893
Novartis Pharmaceuticals Corporation
$1,892
AbbVie Inc.
$1,357
PFIZER INC.
$1,157
ABBVIE INC.
$1,151
Horizon Therapeutics plc
$1,092
Aurinia Pharma U.S., Inc.
$764
GlaxoSmithKline, LLC.
$744
Lilly USA, LLC
$737
GENZYME CORPORATION
$621
Celgene Corporation
$522
Genentech USA, Inc.
$467
AbbVie, Inc.
$450
Boehringer Ingelheim Pharmaceuticals, Inc.
$361
E.R. Squibb & Sons, L.L.C.
$354
AstraZeneca Pharmaceuticals LP
$339
Antares Pharma, Inc.
$313
Horizon Pharma plc
$309
Organon LLC
$204
Radius Health, Inc.
$178
MEDEXUS PHARMA, INC.
$145
Hikma Pharmaceuticals USA
$136
Alexion Pharmaceuticals, Inc.
$125
Mallinckrodt Hospital Products Inc.
$124
SANOFI-AVENTIS U.S. LLC
$124
Sandoz Inc.
$118
Mallinckrodt Enterprises LLC
$112
Takeda Pharmaceuticals U.S.A., Inc.
$98
Mallinckrodt LLC
$92
Janssen Pharmaceuticals, Inc
$83
ANI Pharmaceuticals, Inc.
$79
MEDAC PHARMA, INC.
$74
Fresenius Kabi USA, LLC
$64
Actelion Pharmaceuticals US, Inc.
$64
Zyla Life Sciences
$63
Merck Sharp & Dohme Corporation
$50
Organon Llc
$42
SCILEX PHARMACEUTICALS INC.
$38
Octapharma USA, Inc.
$34
Ultragenyx Pharmaceutical Inc.
$25
SOBI, INC
$25
Biocon Biologics Inc
$24
Gilead Sciences, Inc.
$23
Kyowa Kirin, Inc.
$23
Teva Pharmaceuticals USA, Inc.
$21
Ironwood Pharmaceuticals, Inc
$18
Biogen, Inc.
$17
Pharmacosmos Therapeutics Inc.
$16
Janssen Scientific Affairs, LLC
$15
FIDIA PHARMA USA INC.
$14
Exeltis, USA Inc.
$12
West-Ward Pharmaceuticals
$12
Top 3 companies account for 39.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AMJEVITA · AVSOLA · Actemra · BENLYSTA · BOSENTAN TABLETS · Bimzelx · COSENTYX · CRYSVITA · CUVITRU · CYLTEZO · Cimzia · Crysvita · DUZALLO · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · HYQVIA · HYRIMOZ · Hulio · Humira · Hymovis · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MONOFERRIC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · UPTRAVI · Uloric · XELJANZ · XYOSTED · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for rheumatology in GA.

Looking for a rheumatology specialist in Macon?
Compare rheumatologists in the Macon area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
5
Per 100K population
3.2
County median income
$50,747
Nearest hospital
ATRIUM HEALTH NAVICENT THE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Crowley is a mixed practice specialist, with above-average Medicare volume (top 23% in GA), with low-engagement industry engagement in the top 10% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Crowley experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Crowley performed 19,482 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Crowley receive payments from pharmaceutical companies?
Yes. Dr. Crowley received a total of $24,583 from 54 companies across 1,410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crowley's costs compare to other rheumatologists in Macon?
Dr. Crowley's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crowley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →